Skip to main content

Advertisement

We are working on a new version of this page and we'd like your opinion. See an early preview or learn more.

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Inhibitor of differentiation 4 (Id4) is a potential tumor suppressor in prostate cancer

  • Jason PW Carey1,
  • Ananthi J Asirvatham1,
  • Oliver Galm2,
  • Tandeih A Ghogomu1 and
  • Jaideep Chaudhary1Email author
BMC Cancer20099:173

https://doi.org/10.1186/1471-2407-9-173

Received: 31 July 2008

Accepted: 07 June 2009

Published: 07 June 2009

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
31 Jul 2008 Submitted Original manuscript
3 Sep 2008 Reviewed Reviewer Report - Fred Sablitzky
5 Sep 2008 Reviewed Reviewer Report - Juan Lacal
10 Oct 2008 Author responded Author comments - Jaideep Chaudhary
Resubmission - Version 2
10 Oct 2008 Submitted Manuscript version 2
28 Oct 2008 Author responded Author comments - Jaideep Chaudhary
Resubmission - Version 3
28 Oct 2008 Submitted Manuscript version 3
30 Oct 2008 Reviewed Reviewer Report - Fred Sablitzky
13 Nov 2008 Reviewed Reviewer Report - Juan Lacal
23 Mar 2009 Author responded Author comments - Jaideep Chaudhary
Resubmission - Version 4
23 Mar 2009 Submitted Manuscript version 4
11 May 2009 Reviewed Reviewer Report - Juan Lacal
2 Jun 2009 Author responded Author comments - Jaideep Chaudhary
Resubmission - Version 5
2 Jun 2009 Submitted Manuscript version 5
Publishing
7 Jun 2009 Editorially accepted
7 Jun 2009 Article published 10.1186/1471-2407-9-173

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Biology, Center for Cancer Research and Therapeutics Development, Clark Atlanta University
(2)
Medizinische Klinik IV, Universitaetsklinikum Aachen, RWTH Aachen

Advertisement